Neuraegis, Inc

Website
5001 Alcorn Ln
Irvine, CA 92603

Neuraegis, Inc. is a preclinical-stage neuropharmaceutical company based in Irvine, California, focused on pioneering the development of novel protease inhibitors for the treatment of neurological disorders, including traumatic brain injury (TBI), concussion, and epilepsy. With an initial emphasis on TBI, where there are currently no FDA-approved treatments, the company aims to address significant unmet medical needs in this area.

Recognizing TBI as a major public health issue, Neuraegis is committed to advancing first-in-class compounds that target neuronal damage and death following injury. The company has garnered attention for its strong intellectual property portfolio and experienced leadership team, as well as receiving substantial grants from the Department of Defense to support its research initiatives.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

United StatesCaliforniaIrvineNeuraegis, Inc

Partial Data by Infogroup (c) 2024. All rights reserved.